NCT03047499Unknown不适用
Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleftlip Repair by Modified Millard Cheiloplasty
Mostafa Khairy1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2017年2月15日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 2
- 试验地点
- 1
- 主要终点
- Scar Length
研究概览
简要总结
Evaluation of the effect of botulinum toxin type-A injection prior to surgical correction of complete unilateral cleftlip repair by modified millard cheiloplasty
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 3 Months 至 6 Months（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Primary cleft lip
排除标准
- •Cleft palate
研究组 & 干预措施
Scar Length
干预措施: Botulinum toxin type A (Drug)
Vancouver scar scale
干预措施: Botulinum toxin type A (Drug)
Scar width
干预措施: Botulinum toxin type A (Drug)
结局指标
主要结局
Scar Length
时间窗: 6 months
次要结局
未报告次要终点
研究者
Mostafa Khairy
Mostafa Khairy
Cairo University
研究点 (1)
Loading locations...
相似试验
终止
不适用
The Effect of Botulinum Toxin A Injections on Ankle Dorsiflexion Following Internal Fixation of Tibial Pilon FracturesEquinus ContractureNCT02051933Wake Forest University Health Sciences10
尚未招募
不适用
Botulinum toxin type A injections in stiff knee gait.In the Netherlands live about 18.000 Cerebro Vascular Accident (CVA)-patients which discover problems with walking caused by insufficient footclearance. Causes of problems with the footclearance during the swing phase of gait are a combination of diminished dorsal flexion of the ankle, knee flexion and hip flexion. A diminished knee flexion during swing is defined a stiff knee gait. A stiff knee gait is often caused by an overactivity of the m. rectus femoris. Keywords: stroke, stiff knee gaitNL-OMON29171Roessingh Research and DevelopmentRoessinghsbleekweg 337577 AH Enschede26
已完成
2 期
The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar FormationMammary DisorderHypertrophic ScarScarNCT03887377Henry Ford Health System22
尚未招募
3 期
Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's DiseaseBuerger DiseaseRaynaud SyndromeNCT05698979University Hospital, Toulouse8
已完成
3 期
Study of Botulinum Toxin and Recovery of Hand Function After StrokeStroke With HemiparesisNCT01422161NYU Langone Health16